Mostrar el registro sencillo del ítem

dc.contributor.authorBurgos-Molina, Antonio Manuel 
dc.contributor.authorPeinado-Ruiz, Isabel C.
dc.contributor.authorGonzález Vidal, Alejandro
dc.contributor.authorRuiz-Gómez, Miguel José 
dc.date.accessioned2022-12-21T10:29:30Z
dc.date.available2022-12-21T10:29:30Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/10630/25657
dc.description.abstractThe increase in the concentration of HSP in tumour cells produces an increase in the capacity for replication, migration, and drug resistance. HSP and HSF1 factor are involved in the etiology of breast cancer. The overexpression of HSP27, HSP40, HSP70, HSP90 and HSF1 in breast cancer leads to increased multidrug resistance, inhibition of apoptotic cell death, and acceleration of tumour progression. Furthermore, the presence of very high levels of HSP90 resulted in a ductal type carcinoma.es_ES
dc.description.sponsorshipUniversidad de Málaga. Campus de Excelencia Internacional Andalucía Tech.es_ES
dc.language.isoenges_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCélulas humanas - Investigaciónes_ES
dc.subject.otherHeat shock proteins overexpressed in tumour cellses_ES
dc.subject.otherAgeing and celular resistance to treatmentes_ES
dc.titleHeat shock proteins overexpressed in tumour cells and their relationship with ageing and cellular resistance to treatmentes_ES
dc.typeinfo:eu-repo/semantics/conferenceObjectes_ES
dc.centroFacultad de Medicinaes_ES
dc.relation.eventtitle18th ASEICA INTERNATIONAL CONGRESSes_ES
dc.relation.eventplaceSantiago de Compostela, España.es_ES
dc.relation.eventdate16 al 18 de Noviembre 2022es_ES
dc.rights.ccAttribution-NonCommercial-NoDerivatives 4.0 Internacional*


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional